{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:59:40Z","timestamp":1791316780471,"version":"4.3.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-2006"],"award-info":[{"award-number":["UKDRI-2006"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","award":["1260475"],"award-info":[{"award-number":["1260475"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002203","name":"Brain Tumor Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS088566"],"award-info":[{"award-number":["R01 NS088566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ccell.2025.06.005","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:05:35Z","timestamp":1750939535000},"page":"1608-1621.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gene context drift identifies drug targets to mitigate cancer treatment resistance"],"prefix":"10.1016","volume":"43","author":[{"given":"Amir","family":"Jassim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit V.","family":"Nimmervoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica T.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Masih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Katyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Akhbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben J.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton","family":"Terhune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Balmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean E.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella G.","family":"Filbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anarita","family":"Patrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Dani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.06.005_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s42003-021-02257-0","article-title":"When dormancy fuels tumour relapse","volume":"4","author":"Santos-de-Frutos","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ccell.2025.06.005_bib2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1158\/0008-5472.CAN-21-3695","article-title":"Understanding Drug Sensitivity and Tackling Resistance in Cancer","volume":"82","author":"Tyner","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.005_bib3","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/1535-7163.MCT-18-0727","article-title":"Differences in signaling patterns on PI3K inhibition reveal context specificity in KRAS mutant cancers","volume":"18","author":"Stewart","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2025.06.005_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2017.10.007","article-title":"Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer","volume":"32","author":"Sun","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41568-023-00602-5","article-title":"Cancers make their own luck: theories of cancer origins","volume":"23","author":"Jassim","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"Lopez","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.06.005_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.06.005_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3747\/co.27.5951","article-title":"The cost of failed first-line cancer treatment related to continued smoking in Canada","volume":"27","author":"Iragorri","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trecan.2018.01.001","article-title":"The Genetic\/Non-genetic Duality of Drug \u2018Resistance\u2019 in Cancer","volume":"4","author":"Salgia","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"10","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib15","doi-asserted-by":"crossref","first-page":"1257601","DOI":"10.1126\/science.1257601","article-title":"Disease networks. Uncovering disease-disease relationships through the incomplete interactome","volume":"347","author":"Menche","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.06.005_bib16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.06.005_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14082043","article-title":"Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study","volume":"14","author":"Federico","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ccell.2025.06.005_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-019-2642-7","article-title":"Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets","volume":"20","author":"Amzallag","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ccell.2025.06.005_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45236-6","article-title":"In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data","volume":"9","author":"Celebi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.06.005_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11060-014-1616-x","article-title":"Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management","volume":"121","author":"Cannon","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/nop\/npac062","article-title":"Incidence and survival of choroid plexus tumors in the United States","volume":"10","author":"Takaoka","year":"2023","journal-title":"Neuro-Oncol. Pract."},{"key":"10.1016\/j.ccell.2025.06.005_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27031","article-title":"Pediatric choroid plexus carcinoma: Biologically and clinically in need of new perspectives","volume":"65","author":"Zaky","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ccell.2015.04.005","article-title":"Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes","volume":"27","author":"Tong","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib24","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1158\/1078-0432.CCR-17-2168","article-title":"Establishing a Preclinical Multidisciplinary Board for Brain Tumors","volume":"24","author":"Nimmervoll","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.005_bib25","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1016\/j.cell.2021.04.003","article-title":"A cellular and spatial map of the choroid plexus across brain ventricles and ages","volume":"184","author":"Dani","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1158\/2159-8290.CD-20-0926","article-title":"Maturation Block in Childhood Cancer","volume":"11","author":"Behjati","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.06.005_bib27","first-page":"855","article-title":"node2vec: Scalable Feature Learning for Networks","volume":"2016","author":"Grover","year":"2016","journal-title":"KDD"},{"key":"10.1016\/j.ccell.2025.06.005_bib28","series-title":"Efficient Estimation of Word Representations in Vector Space","author":"Mikolov","year":"2013"},{"key":"10.1016\/j.ccell.2025.06.005_bib29","doi-asserted-by":"crossref","first-page":"13182","DOI":"10.1073\/pnas.0504211102","article-title":"A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM","volume":"102","author":"Sun","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.06.005_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trecan.2020.09.005","article-title":"Cancer Plasticity: The Role of mRNA Translation","volume":"7","author":"Lee","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.06.005_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ccell.2025.06.005_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/neuonc\/noaa238","article-title":"Brain exposure of the ATM inhibitor AZD1390 in humans\u2014a positron emission tomography study","volume":"23","author":"Jucaite","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ccell.2025.06.005_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.csbj.2022.11.055","article-title":"scDrug: From single-cell RNA-seq to drug response prediction","volume":"21","author":"Hsieh","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ccell.2025.06.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114270","article-title":"Dark force rising: Reawakening and targeting of fetal-like stem cells in colorectal cancer","volume":"43","author":"Fey","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.06.005_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71188-7","article-title":"Epigenetic silencing of ZIC4 unveils a potential tumor suppressor role in pediatric choroid plexus carcinoma","volume":"14","author":"Hesham","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.06.005_bib38","first-page":"vdaa168","article-title":"Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial","volume":"3","author":"Liu","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.ccell.2025.06.005_bib39","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.cell.2021.03.023","article-title":"Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion","volume":"184","author":"Gangoso","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","article-title":"Article Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma","volume":"187","author":"Kirschenbaum","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcmgh.2018.01.012","article-title":"siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth","volume":"5","author":"Duggan","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ccell.2025.06.005_bib42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib43","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JCO.20.01372","article-title":"Outcomes by Clinical and Molecular Features in Children with Medulloblastoma Treated with Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)","volume":"39","author":"Gajjar","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib44","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1470-2045(13)70449-2","article-title":"Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis","volume":"14","author":"Ramaswamy","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41586-024-07384-2","article-title":"The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer","volume":"629","author":"Abraham","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.06.005_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59151-0","article-title":"Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II\/III trial","volume":"16","author":"Abraham","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.06.005_bib47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41698-024-00723-6","article-title":"Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer","volume":"8","author":"Otsuji","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.06.005_bib49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.06.005_bib51","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1002\/cphg.70","article-title":"Multicolor Fluorescence In Situ Hybridization (FISH) Approaches for Simultaneous Analysis of the Entire Human Genome","volume":"99","author":"Zhang","year":"2018","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.ccell.2025.06.005_bib52","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ng.3323","article-title":"An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes","volume":"47","author":"Mohankumar","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.06.005_bib53","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/bioinformatics\/bty316","article-title":"CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones","volume":"34","author":"M\u00fcller","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2025.06.005_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02289451","article-title":"A generalized solution of the orthogonal procrustes problem","volume":"31","author":"Sch\u00f6nemann","year":"1966","journal-title":"Psychometrika"},{"key":"10.1016\/j.ccell.2025.06.005_bib55","series-title":"RAWGraphs: A visualisation platform to create open outputs. Proceedings of the 12th Biannual Conference on Italian SIGCHI Chapter","author":"Mauri","year":"2017"},{"key":"10.1016\/j.ccell.2025.06.005_bib56","article-title":"OmicVerse: A single pipeline for exploring the entire transcriptome universe","author":"Zeng","year":"2023","journal-title":"bioRxiv"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825002557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825002557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:06:28Z","timestamp":1762549588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825002557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1535610825002557"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.06.005","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene context drift identifies drug targets to mitigate cancer treatment resistance","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}